# Depakote ER in Borderline Personality Disorder

> **NCT00222482** · NA · COMPLETED · sponsor: **University of Minnesota** · enrollment: 15 (—)

## Conditions studied

- Borderline Personality Disorder

## Interventions

- **DRUG:** Depakote ER

## Key facts

- **NCT ID:** NCT00222482
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 15 (—)
- **Last updated:** 2007-08-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222482, "Depakote ER in Borderline Personality Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00222482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*